Epigallocatechin Gallate → Hesperidin

참여 물질

역할	이름	HCID	투입량
반응물	Epigallocatechin Gallate	HCID 65064	—
반응물	(2S)-2-(3,4-dimethoxyphenyl)-5-hydroxy-7-((2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl)oxan-2-yl)oxy-2,3-dihydrochromen-4-one	HCID 3035218	—
생성물	Hesperidin	HCID 10621	—
생성물	(2S)-2-(3,4-dimethoxyphenyl)-5-hydroxy-7-((2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl)oxan-2-yl)oxy-2,3-dihydrochromen-4-one	HCID 3035218	—

반응 단계

A hesperidin composition was obtained as a hesperidin-containing aqueous solution by a same procedure as in Example 1, except that a methylhesperidin preparation (manufactured by Hamari Chemicals Ltd., methylhesperidin content 100%, the same shall apply hereafter) was used instead of the EGCG preparation. Reaction conditions and the measurement result of a concentration of hesperidin and methylhesperidin in the composition are shown in Table 1.

출처 및 근거

DOI	10.6084/m9.figshare.5104873.v1
특허 번호	US09079933B2
출처 데이터셋	uspto-grants-2015_07
ORD ID	ord-e800ded5b7514afcbd1973e8261151bb
출처 메모	uspto-grants-2015_07